Benefits Seen With Deutetrabenazine in Tardive Dyskinesia Regardless of Age
Treatment with deutetrabenazine was found to be beneficial for both younger (<55 years) and older (≥55 years) patients with tardive dyskinesia, according to findings from a recently published post hoc analysis.